Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lianhua Qingke granules for pediatric acute bronchitis (phlegm-heat obstructing lung) – Phase II randomized double-blind low-dose controlled multicenter study
CTR20243918Phase 2Completed
- Sponsor
- Yiling Pharmaceutical
- Start
- Nov 2024
- Countries
- 1
01
Overview
A Phase 2 trial of Lianhua Qingke Granules in acute bronchitis, sponsored by Yiling Pharmaceutical. Started Nov 2024; status: completed.
02
Drugs
Lianhua Qingke Granules
03
Conditions
acute bronchitis
Beyond the preview
Go deeper on CTR20243918.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20243918.